<< Research reveals that iPSCs similar to embryonic stem cells | Insulin metabolism regulates body's internal clock >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Ελληνικά | Русский | Svenska | Polski

Also in global health news: HIV/AIDS in Bangladesh; river blindness in Tanzania; potential immune system booster; compounds might fight TB

Published on September 18, 2009 at 1:50 AM · No Comments

U.S. Commits $13M To Fight HIV/AIDS In Bangladesh

BDNews24.com reports on a new $13 million U.S.-government initiative aimed at "providing HIV-prevention services to two million at-risk people in Bangladesh including injecting drug users, male, female and transgender sex workers and their clients, and HIV-positive people through a network of 50 health centres." USAID will partner with Family Health International (FHI) to implement the program (9/17).

NewsHour Examines River Blindness In Tanzania

For the second piece in a three-part series, PBS' NewsHour examines efforts to combat onchocerciasis, also known as river blindness, in Tanzania, including a recent effort, which resulted in a "dramatic drop" in the number of cases of the disease. The show also explores why river blindness is often eclipsed by deadlier diseases like AIDS and malaria (Suarez, 9/16).

French Food Company Says Clinical Trials Show Potential Food Product Boosts Immune System In Patients With HIV

The French food company Danone reported Wednesday that clinical trials of a substance it plans to develop into a nutritional product over the next few years helped improve the immune systems of patients living with HIV, Bloomberg reports (Bauerova, 9/16). "The evidence is now building that medical nutrition may be able to make a difference in the lives of patients not only in HIV but across a broad spectrum of immune-related conditions," said Flemming Morgan, president of the medical nutrition division of Danone, the Financial Times reports (Jack, Wiggins and Daneshkhu, 9/16).

Two Compounds Kill Dormant TB, Could Lead To New Drugs, Study Says

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading